The Journal of Hip Surgery 2017; 01(03): 140-145
DOI: 10.1055/s-0037-1605386
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Heart Failure and Total Hip Arthroplasty: What Are the Perioperative Outcomes and Complications?

Gannon Curtis
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Jaiben George
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Jared M. Newman
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Alison K. Klika
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Wael K. Barsoum
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Carlos A. Higuera
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

10 June 2017

05 July 2017

Publication Date:
09 August 2017 (online)

Abstract

Heart failure (HF) has been reported to cause morbidity and mortality after surgery. As the prevalence of HF and hip osteoarthritis increase, physicians are likely to observe a rise in the number of HF patients requiring total hip arthroplasty (THA). We asked (1) what perioperative outcomes can be expected for patients with HF after THA, and (2) does HF contribute to an increased risk of short-term complications after THA? The National Surgical Quality Improvement Program database was accessed to find patients with osteoarthritis who underwent THA from 2008 to 2014. The HF cohort included 177 patients, while the control group consisted of 64,619 patients. Demographics, comorbidities, outcomes, and complications were collected. Multivariate regression analysis was performed. HF patients were found to have longer hospital stays (β = 0.87; p = 0.004) and were less likely to be discharged home (OR = 1.77, p = 0.001) following THA. It also increased the risk for any complication (OR = 1.54, p = 0.011), mortality (OR = 3.67, p = 0.042), readmission (OR = 1.68, p = 0.041), cardiac arrest (OR = 8.44, p = 0.006), myocardial infarction (OR = 3.75, p = 0.014), and deep surgical site infection (OR = 3.62, p = 0.035). HF patients had longer hospital stays and were discharged to a facility after THA. Overall, they had an increased risk of any complication, readmission, cardiac arrest, myocardial infarction, and deep surgical site infection. Moreover, the mortality risk after THA was significantly high. Cardiac optimization could play a key role in the prevention of these adverse outcomes. Patients should be counseled prior to surgery.

 
  • References

  • 1 Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009; 302 (04) 394-400
  • 2 Go AS, Mozaffarian D, Roger VL. , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013; 127 (01) e6-e245
  • 3 Curtis LH, Whellan DJ, Hammill BG. , et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med 2008; 168 (04) 418-424
  • 4 Roger VL, Weston SA, Redfield MM. , et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292 (03) 344-350
  • 5 Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87 (07) 1487-1497
  • 6 Fingar KR. (Truven Health Analytics), Stocks C (AHRQ), Weiss AJ (Truven Health Analytics) SC (AHRQ). Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003–2012. HCUP Statistical Brief #186. Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb186-Operating-Room-Procedures-United-States-2012.jsp . Accessed December 1, 2016
  • 7 Upshaw J, Kiernan MS. Preoperative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep 2013; 10 (02) 147-156
  • 8 Hammill BG, Curtis LH, Bennett-Guerrero E. , et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 2008; 108 (04) 559-567
  • 9 Hernandez AF, Whellan DJ, Stroud S, Sun JL, O'Connor CM, Jollis JG. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 2004; 44 (07) 1446-1453
  • 10 NSQIP. American College of Surgeons National Surgical Quality Improvement Program. Available at: https://www.facs.org/quality-programs/acs-nsqip Accessed August 11, 2016
  • 11 Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 2013; 20 (10) 3212-3217
  • 12 Khuri SF. The NSQIP: a new frontier in surgery. Surgery 2005; 138 (05) 837-843
  • 13 User Guide for the 2014 ACS NSQIP Participant Use Data File (PUF). 2015 . Available at: https://www.facs.org/~/media/files/quality programs/nsqip/nsqip_puf_userguide_2014.ashx . Accessed December 2, 2016
  • 14 Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty 2013; 28 (09) 1499-1504
  • 15 Bozic KJ, Lau E, Kurtz S. , et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012; 94 (09) 794-800
  • 16 Lee S, Hwang JI, Kim Y, Yoon PW, Ahn J, Yoo JJ. Venous thromboembolism following hip and knee replacement arthroplasty in Korea: a nationwide study based on claims registry. J Korean Med Sci 2016; 31 (01) 80-88
  • 17 Cohen ME, Dimick JB, Bilimoria KY, Ko CY, Richards K, Hall BL. Risk adjustment in the American College of Surgeons National Surgical Quality Improvement Program: a comparison of logistic versus hierarchical modeling. J Am Coll Surg 2009; 209 (06) 687-693
  • 18 Cohen ME, Ko CY, Bilimoria KY. , et al. Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg 2013; 217 (02) 336-346.e1
  • 19 Lawson EH, Louie R, Zingmond DS. , et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg 2012; 256 (06) 973-981
  • 20 Gholson JJ, Shah AS, Gao Y, Noiseux NO. Morbid obesity and congestive heart failure increase operative time and room time in total hip arthroplasty. J Arthroplasty 2016; 31 (04) 771-775
  • 21 Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res 2011; 469 (05) 1391-1400
  • 22 Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee GC. Should all patients be included in alternative payment models for primary total hip arthroplasty and total knee arthroplasty?. J Arthroplasty 2016; 31 (9, Suppl) 45-49
  • 23 Menendez ME, Baker DK, Fryberger CT, Ponce BA. Predictors of extended length of stay after elective shoulder arthroplasty. J Shoulder Elbow Surg 2015; 24 (10) 1527-1533
  • 24 Chung F, Mezei G. Factors contributing to a prolonged stay after ambulatory surgery. Anesth Analg 1999; 89 (06) 1352-1359
  • 25 Keswani A, Tasi MC, Fields A, Lovy AJ, Moucha CS, Bozic KJ. Discharge destination after total joint arthroplasty: an analysis of postdischarge outcomes, placement risk factors, and recent trends. J Arthroplasty 2016; 31 (06) 1155-1162
  • 26 Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Patient expectation is the most important predictor of discharge destination after primary total joint arthroplasty. J Arthroplasty 2015; 30 (04) 539-542
  • 27 Belmont Jr PJ, Goodman GP, Hamilton W, Waterman BR, Bader JO, Schoenfeld AJ. Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence. J Arthroplasty 2014; 29 (10) 2025-2030
  • 28 SooHoo NF, Li Z, Chan V, Chenok K, Bozic KJ. The importance of risk adjustment in reporting total joint arthroplasty outcomes. J Arthroplasty 2016; 31 (03) 590-595
  • 29 Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee GC. Late complications following elective primary total hip and knee arthroplasty: who, when, and how?. J Arthroplasty 2017; 32 (03) 719-723
  • 30 Ricciardi BF, Oi KK, Daines SB, Lee YY, Joseph AD, Westrich GH. Patient and perioperative variables affecting 30-day readmission for surgical complications after hip and knee arthroplasties: a matched cohort study. J Arthroplasty 2017; 32 (04) 1074-1079
  • 31 Saucedo JM, Marecek GS, Wanke TR, Lee J, Stulberg SD, Puri L. Understanding readmission after primary total hip and knee arthroplasty: who's at risk?. J Arthroplasty 2014; 29 (02) 256-260
  • 32 Basilico FC, Sweeney G, Losina E. , et al. Risk factors for cardiovascular complications following total joint replacement surgery. Arthritis Rheum 2008; 58 (07) 1915-1920
  • 33 Belmont Jr PJ, Goodman GP, Kusnezov NA. , et al. Postoperative myocardial infarction and cardiac arrest following primary total knee and hip arthroplasty: rates, risk factors, and time of occurrence. J Bone Joint Surg Am 2014; 96 (24) 2025-2031
  • 34 Menendez ME, Memtsoudis SG, Opperer M, Boettner F, Gonzalez Della Valle A. A nationwide analysis of risk factors for in-hospital myocardial infarction after total joint arthroplasty. Int Orthop 2015; 39 (04) 777-786
  • 35 Poultsides LA, Ma Y, Della Valle AG, Chiu YL, Sculco TP, Memtsoudis SG. In-hospital surgical site infections after primary hip and knee arthroplasty--incidence and risk factors. J Arthroplasty 2013; 28 (03) 385-389
  • 36 Pugely AJ, Martin CT, Gao Y, Schweizer ML, Callaghan JJ. The Incidence of and risk factors for 30-day surgical site infections following primary and revision total joint arthroplasty. J Arthroplasty 2015; 30 (9, Suppl) 47-50